Zdrowie i gospodarka · 21/08/2002

FDA Releases Draft Guidance on Handling and Retention of Bioavailability and Bioequivalence Testing Samples

The Food and Drug Administration (FDA) has made available a draft guidance document aimed at improving the handling and retention of reserve samples used in bioavailability and bioequivalence testing studies, which often lack these essential samples at testing facilities.